The following table shows the list of Horizon 2020 projects developed by "INSTITUT DE RECHERCHES INTERNATIONALES SERVIER". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | REPROGRAM | H2020-EU.3.1.1. | participant | 225˙000.00 | 2016-01-01 | 816 |
2 | ADAPT-SMART | H2020-EU.3.1.7.13. | participant | 0.00 | 2015-07-01 | 688 |
3 | TransQST | H2020-EU.3.1.7. | participant | 0.00 | 2017-01-01 | 893 |
4 | DO-IT | H2020-EU.3.1.7. | participant | 0.00 | 2017-02-01 | 1014 |
5 | BigData Heart | H2020-EU.3.1.7. | participant | 0.00 | 2017-03-01 | 796 |
6 | eTRANSAFE | H2020-EU.3.1.7. | participant | 0.00 | 2017-09-01 | 869 |
7 | INSIST | H2020-EU.3.1.5. | participant | 85˙500.00 | 2017-11-01 | 831 |
8 | PARADIGM | H2020-EU.3.1.7. | participant | 0.00 | 2018-03-01 | 582 |
9 | c4c | H2020-EU.3.1.7. | participant | 0.00 | 2018-05-01 | 375 |
10 | NECESSITY | H2020-EU.3.1.7. | participant | 0.00 | 2019-01-01 | 331 |
11 | EHDEN | H2020-EU.3.1.7. | participant | 0.00 | 2018-11-01 | 340 |
12 | IMMUcan | H2020-EU.3.1.7. | participant | 0.00 | 2019-03-01 | 323 |
13 | EU-PEARL | H2020-EU.3.1.7. | participant | 0.00 | 2019-11-01 | 315 |
totale | 310˙500.00 |
This organization collaborated with partners in 27 countries.
Within the project REPROGRAM this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | PL | SENSILAB Polska | SENSILAB POLSKA SP ZOO - SKA (PRC) |
participant | NL | DSC | DESCIN BV (PRC) |
participant | US | MGH | THE GENERAL HOSPITAL CORPORATION (OTH) |
coordinator | NL | AMC | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (HES) |
participant | DK | REGIONH | REGION HOVEDSTADEN (PUB) |
participant | RO | UMF | UNIVERSITATEA DE MEDICINA SI FARMACIE IULIU HATIEGANU CLUJ-NAPOCA (HES) |
participant | CH | UZH | UNIVERSITAT ZURICH (HES) |
participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | IT | UMIL | UNIVERSITA DEGLI STUDI DI MILANO (HES) |
Within the project ADAPT-SMART this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CH | SHIRE | SHIRE INTERNATIONAL GMBH (PRC) |
participant | UK | AbbVie | AbbVie Ltd (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
participant | FR | Lysogene | LYSOGENE (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | UK | Astellas | ASTELLAS PHARMA EUROPE LTD (PRC) |
participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
participant | FR | HAS | HAUTE AUTORITE DE SANTE (PUB) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
coordinator | NL | LYGATURE | STICHTING LYGATURE (OTH) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | US | MIT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (HES) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DK | DHMA | SUNDHEDSSTYRELSEN (PUB) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project TransQST this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | ABBVIE | ABBVIE DEUTSCHLAND GMBH & CO KG (PRC) |
participant | NL | Oc | OCELLO BV (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DE | IFADO | FORSCHUNGSGESELLSCHAFT FUR ARBEITSPHYSIOLOGIE UND ARBEITSSCHUTZ E.V. (HES) |
participant | UK | SIMCYP | CERTARA UK LIMITED (PRC) |
participant | ES | IMIM | FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM (REC) |
participant | FI | ORION | ORION OYJ (PRC) |
participant | DE | UKL-HD | UNIVERSITATSKLINIKUM HEIDELBERG (HES) |
participant | AT | UW-APRI | UNIVERSITAT WIEN (HES) |
participant | DE | UKA | UNIVERSITAETSKLINIKUM AACHEN (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | NL | ULEI | UNIVERSITEIT LEIDEN (HES) |
participant | NL | UM | UNIVERSITEIT MAASTRICHT (HES) |
coordinator | UK | UOL | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | DE | EMBL | EUROPEAN MOLECULAR BIOLOGY LABORATORY (REC) |
participant | NL | ERASMUS | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
Within the project DO-IT this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | HIQ | HEALTH IQ LIMITED (PRC) |
participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | SE | IHE | IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG (PRC) |
participant | NO | NoMA | STATENS LEGEMIDDELVERK (PUB) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | SE | TLV | TANDVARDS-OCH LAKEMEDELSFORMANSVERKET (PUB) |
participant | ES | FI | ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA (OTH) |
participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
participant | BE | EMSP | THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | DE | InterSystems | INTERSYSTEMS GMBH (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NO | NIPH | FOLKEHELSEINSTITUTTET (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | IT | CERGAS | UNIVERSITA COMMERCIALE LUIGI BOCCONI (HES) |
participant | HU | SU | SEMMELWEIS EGYETEM (HES) |
coordinator | UK | LSE | LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo | NOVO NORDISK A/S (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | ULIV | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project BigData Heart this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CH | VP | VIFOR (INTERNATIONAL) AG (PRC) |
participant | NL | MLCF | STICHTING MLC FOUNDATION (OTH) |
participant | DE | BAY | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | US | ICHOM | INTERNATIONAL CONSORTIUM FOR HEALTHOUTCOMES MEASUREMENT INC. (OTH) |
participant | NL | HYVE | THE HYVE BV (PRC) |
participant | BE | EHN | EUROPEAN HEART NETWORK AISBL (OTH) |
participant | US | SOM | SOMALOGIC INC (PRC) |
participant | FR | ESC | SOCIETE EUROPEENNE DE CARDIOLOGIE (OTH) |
participant | ES | INCLIVA | FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA, FUNDACION INCLIVA (REC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DE | UKE | UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF (HES) |
participant | UK | UB | THE UNIVERSITY OF BIRMINGHAM (HES) |
coordinator | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
Within the project eTRANSAFE this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | JP | Eisai | EISAI CO LTD (PRC) |
participant | UK | Clarivate | CLARIVATE ANALYTICS (UK) LIMITED (PRC) |
participant | UK | PDS | PDS COMPUTER SOFTWARE LIMITED (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | UK | OPTIBRIUM | OPTIBRIUM LIMITED (PRC) |
participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | LL | LHASA LIMITED (REC) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | DE | MN | MOLECULAR NETWORKS GMBH COMPUTERCHEMIE (PRC) |
participant | UK | LJMU | LIVERPOOL JOHN MOORES UNIVERSITY (HES) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | UK | SIMCYP | CERTARA UK LIMITED (PRC) |
coordinator | ES | IMIM | FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | AT | UW-APRI | UNIVERSITAT WIEN (HES) |
participant | ES | UPF | UNIVERSIDAD POMPEU FABRA (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | NL | ULEI | UNIVERSITEIT LEIDEN (HES) |
participant | DE | Fraunhofer | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | DE | EMBL | EUROPEAN MOLECULAR BIOLOGY LABORATORY (REC) |
participant | NL | ERASMUS | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
Within the project INSIST this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | IE | NEURAVI LIMITED | NEURAVI LIMITED (PRC) |
coordinator | NL | AMC | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (HES) |
participant | RU | MSU | M.V. LOMONOSOV MOSCOW STATE UNIVERSITY (HES) |
participant | IT | POLIMI | POLITECNICO DI MILANO (HES) |
participant | CH | UNIGE | UNIVERSITE DE GENEVE (HES) |
participant | IE | NUI GALWAY | NATIONAL UNIVERSITY OF IRELAND GALWAY (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | NL | UVA | UNIVERSITEIT VAN AMSTERDAM (HES) |
participant | NL | ERASMUS | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
Within the project PARADIGM this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | Alexion | ALEXION SERVICES EUROPE SPRL (PRC) |
participant | CA | HTAi | HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY (OTH) |
participant | BE | Synergist | THE SYNERGIST (OTH) |
participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
participant | UK | Amgen | AMGEN LIMITED (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | NL | STICHTING VU | STICHTING VU (HES) |
participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | DE | GRT | GRUNENTHAL GMBH (PRC) |
participant | UK | Covance | COVANCE LABORATORIES LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | LU | AE | ALZHEIMER EUROPE (OTH) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | IACS | INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD (REC) |
participant | DE | EATG | EUROPEAN AIDS TREATMENT GROUP EV (OTH) |
coordinator | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | ES | FSJD | FUNDACIO SANT JOAN DE DEU (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project c4c this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | HU | MCRN-Hungary | GYERMEKGYOGYASZATI KLINIKAI VIZSGALOI HALOZAT (OTH) |
participant | DE | HSK | HELIOS DR. HORST SCHMIDT KLINIKEN WIESBADEN GMBH (PRC) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | AT | OKIDS | OKIDS GMBH (OTH) |
participant | NL | ECAPN-ECNP | ECNP RESEARCH AND SCHOLARSHIP STICHTING (DE ECNP RESEARCH AND SCHOLARSHIP FOUNDATION) (OTH) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | DK | ECFS | EUROPEAN CYSTIC FIBROSIS SOCIETY (OTH) |
participant | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | IT | FGB | FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS (REC) |
participant | CH | SCTO | SWISS CLINICAL TRIAL ORGANISATION (OTH) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | IT | ARSENAL | ARSENAL.IT - CENTRO VENETO RICERCAE INNOVAZIONE PER LA SANITA DIGITALE (REC) |
participant | ES | CHUS | SERVIZO GALEGO DE SAUDE (PUB) |
participant | NO | HUS-Norway | HELSE BERGEN HF*HAUKELAND UNIVERSITY HOSPITAL (HES) |
participant | PT | AIDFM | Associação para Investigação e Desenvolvimento da Faculdade de Medicina (HES) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | BE | SIOPE | SIOP EUROPE ASBL (OTH) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DE | RBMF | ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH (REC) |
participant | IT | OPBG | OSPEDALE PEDIATRICO BAMBINO GESU (OTH) |
participant | IT | IGG | ISTITUTO GIANNINA GASLINI (PUB) |
participant | FI | HUS | HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ (REC) |
participant | PL | IPCZD | INSTYTUT POMNIK CENTRUM ZDROWIA DZIECKA (REC) |
coordinator | IT | PENTA | FONDAZIONE PENTA - FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES - ONLUS (REC) |
participant | ES | FSJD | FUNDACIO SANT JOAN DE DEU (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | DE | UKL-HD | UNIVERSITATSKLINIKUM HEIDELBERG (HES) |
participant | EE | UT | TARTU ULIKOOL (HES) |
participant | EL | AUTH | ARISTOTELIO PANEPISTIMIO THESSALONIKIS (HES) |
participant | CZ | CUNI | UNIVERZITA KARLOVA (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
participant | IE | Tyndall - UCC | UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | UNILIV | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | BE | UGent | UNIVERSITEIT GENT (HES) |
participant | NL | SKU | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project NECESSITY this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | UPDiderot | UNIVERSITE DE PARIS (HES) |
participant | IT | INN-ACTA | INNOVATION ACTA S.R.L. (PRC) |
participant | FR | AFGS | ASSOCIATION FRANCAISE GOUGEROT-SJOGREN (OTH) |
participant | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | FR | HUS | HOPITAUX UNIVERSITAIRES DE STRASBOURG (REC) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | NO | HSUH | HELSE STAVANGER HF (OTH) |
participant | ES | FPS | FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD (REC) |
participant | ES | FCRB | FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA (REC) |
participant | EL | UOA | ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON (HES) |
participant | FR | AP-HP | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | UK | QMUL | QUEEN MARY UNIVERSITY OF LONDON (HES) |
participant | FR | UPD | UNIVERSITE PARIS DESCARTES (HES) |
participant | IT | UNIUD | UNIVERSITA DEGLI STUDI DI UDINE (HES) |
participant | FR | UBO | UNIVERSITE DE BRETAGNE OCCIDENTALE (HES) |
participant | UK | UOB | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | NO | UiB | UNIVERSITETET I BERGEN (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | FR | IPP | INSTITUT PASTEUR (REC) |
coordinator | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project EHDEN this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CZ | Odysseus | ODYSSEUS DATA SERVICES SRO (PRC) |
participant | UK | ICHOM | INTERNATIONAL CONSORTIUM FOR HEALTHOUTCOMES MEASUREMENT LTD (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | US | ABBVIE | ABBVIE INC (PRC) |
participant | NL | THE HYVE | THE HYVE BV (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | SE | UMC | Stiftelsen WHO Collaborating Centre for International Drug Monitoring (REC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | PT | UAVR | UNIVERSIDADE DE AVEIRO (HES) |
participant | EE | TARTU | TARTU ULIKOOL (HES) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
coordinator | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
Within the project IMMUcan this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | LCC | LIGUE NATIONALE CONTRE LE CANCER (REC) |
participant | FR | OWKIN | OWKIN FRANCE (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | BE | IJB | INSTITUT JULES BORDET (HES) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | BE | DDUV | DE DUVE INSTITUTE (REC) |
participant | FR | PIERRE FABRE | INSTITUT DE RECHERCHE PIERRE FABRESAS (PRC) |
participant | FR | CLB | CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD (REC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | LU | LIH | LUXEMBOURG INSTITUTE OF HEALTH (REC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
coordinator | BE | EORTC | EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (REC) |
participant | ES | CRG | FUNDACIO CENTRE DE REGULACIO GENOMICA (REC) |
participant | CH | CHUV | CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (PUB) |
participant | CH | SIB | SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC) |
participant | FR | IC | INSTITUT CURIE (REC) |
participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | CH | UZH | UNIVERSITAT ZURICH (HES) |
participant | IL | WEIZMANN | WEIZMANN INSTITUTE OF SCIENCE (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | CHA | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project EU-PEARL this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Otsuka | OTSUKA NOVEL PRODUCTS GMBH (PRC) |
participant | US | CTF | CHILDREN'S TUMOR FOUNDATION (REC) |
participant | US | SpringWorks | SPRINGWORKS THERAPEUTICS INC (PRC) |
participant | DE | EUROSCAN | EUROSCAN INTERNATIONAL NETWORK EV (REC) |
participant | EE | DocuMental | DOCUMENTAL OU (PRC) |
participant | BE | i-HD | THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA (REC) |
participant | IL | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | NL | EATRIS | EATRIS ERIC (REC) |
participant | UK | BERRY | BERRY CONSULTANTS LLP (PRC) |
participant | UK | AGN | ALLERGAN LIMITED (PRC) |
participant | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | US | TB Alliance | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION (REC) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | PEI | BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL (PUB) |
participant | BE | JPNV | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
coordinator | ES | VHIR | FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA (REC) |
participant | FR | AP-HP | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
participant | BE | CUSTODIX | CUSTODIX NV (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | IT | UNISR | UNIVERSITA VITA-SALUTE SAN RAFFAELE (HES) |
participant | UK | UMAN | THE UNIVERSITY OF MANCHESTER (HES) |
participant | DK | Novo | NOVO NORDISK A/S (PRC) |
participant | SE | Astrazeneca | ASTRAZENECA AB (PRC) |
participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | IT | UMIL | UNIVERSITA DEGLI STUDI DI MILANO (HES) |